Ftse Mib
33.951,24
0,61%
DAX
17.953,23
0,17%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.838,22
-0,69%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE West Pharmaceutical Services Inc (WST) West Pharmaceutical Services Inc (WST) Notizie

West Pharmaceutical Services Inc

WST
363,43
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:04:00
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202412:00PRNUSWest to Participate in Upcoming Investor Conference
25/4/202412:00PRNUSWest Announces First-Quarter 2024 Results and Declares..
11/4/202412:00PRNUSWest to Host First-Quarter 2024 Conference Call
01/3/202422:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01/3/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:30PRNUSWest to Participate in Upcoming Investor Conferences
27/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:44EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202412:00PRNUSWest Announces Second-Quarter 2024 Dividend
15/2/202413:51EDGAR2Form 8-K - Current report
15/2/202412:00PRNUSWest Announces Fourth-Quarter and Full-Year 2023 Results
07/2/202414:00PRNUSWest Named to Newsweek's America's Greatest Workplaces 2024..
01/2/202412:00PRNUSWest to Host Fourth-Quarter and Full-Year 2023 Conference..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202318:54EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
13/12/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202312:00PRNUSWest Announces First-Quarter 2024 Dividend
06/12/202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202321:46DJNWest Gets FDA 510(k) Clearance for Vial2Bag Advanced 13mm..
04/12/202321:00PRNUSWest Receives FDA 510(k) Clearance for Vial2Bag Advanced®..
30/11/202322:05EDGAR2Form 8-K - Current report
13/11/202313:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
02/11/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202311:00PRNUSWest to Participate in Upcoming Investor Conferences
26/10/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202313:41EDGAR2Form 8-K - Current report
26/10/202312:00PRNUSWest Announces Third-Quarter 2023 Results, Updates Full-Year..
23/10/202312:00PRNUSWest to Attend and Showcase Industry Leadership in Packaging..
16/10/202312:00PRNUSWest to Present on Development of Large Volume Delivery..
12/10/202312:00PRNUSWest to Host Third-Quarter 2023 Conference Call
21/9/202322:33EDGAR2Form 8-K/A - Current report: [Amend]
07/9/202312:00PRNUSWest to Participate in Upcoming Investor Conference
01/9/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 363,43

La tua Cronologia

NYSE
WST
West Pharmaceutical Serv...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network